ReviewTherapeutics and clinical risk management2023

Rifaximin Alfa and Liver Diseases: More Than a Treatment for Encephalopathy, a Disease Modifier.

Aldo Torre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.